Document ID: chunk:federal_register_of_legislation:F2023L00943:reg:9
Version: federal_register_of_legislation:F2023L00943
Segment Type: reg
Provision Reference: reg 9
Character Range: 4057–6828

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the stomach or death from malignant neoplasm of the stomach is connected with the circumstances of a person's relevant service:
(1)          having smoked tobacco products:
(a)          in an amount of at least 25 pack-years before the clinical onset of malignant neoplasm of the stomach; and
(b)          commencing at least 10 years before the clinical onset of malignant neoplasm of the stomach; and
if smoking has ceased before the clinical onset of malignant neoplasm of the stomach, then that onset occurred within 15 years of cessation;
Note: one pack-year is defined in the Schedule 1 – Dictionary.
(2)          having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the stomach at least 10 years before the clinical onset of malignant neoplasm of the stomach;
Note: cumulative equivalent dose is defined in the Schedule 1 – Dictionary.
(3)          having infection with Helicobacter pylori at least 10 years before the clinical onset of malignant neoplasm of the stomach;
(4)          having chronic atrophic gastritis, where the chronic atrophic gastritis commenced at least 5 years before the clinical onset of malignant neoplasm of the stomach;
Note: chronic atrophic gastritis is defined in the Schedule 1 – Dictionary.
(5)          having undergone a partial gastrectomy at least 10 years before the clinical onset of malignant neoplasm of the stomach;
(6)          for cardia stomach carcinoma only, being obese for at least the 5 years before the clinical onset of malignant neoplasm of the stomach;
Note: cardia stomach carcinoma and being obese are defined in the Schedule 1 – Dictionary.
(7)          having a gastric ulcer at least 10 years before the clinical onset of malignant neoplasm of the stomach;
(8)          having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical onset of malignant neoplasm of the stomach;
Note: specified list of autoimmune diseases is defined in the Schedule 1 – Dictionary.
(9)          for non-cardia stomach carcinoma only, taking a proton pump inhibitor drug for at least a continuous period of 2 year within the 5 years before the clinical onset of malignant neoplasm of the stomach, and where the last dose of the drug was taken at least 1 year before the clinical onset of malignant neoplasm of the stomach;
Note: non-cardia stomach carcinoma is defined in the Schedule 1 – Dictionary.
(10)      inability to obtain appropriate clinical management for malignant neoplasm of the stomach before the clinical worsening of malignant neoplasm of the stomach.